CHEK1 and pancreatic neoplasm: Our findings on APE2 in the ATR-Chk1 DDR pathway in both the Xenopus system and pancreatic cancer cells prompt us to target the function and regulatory mechanism of APE2 in the ATR DDR pathway for cancer therapy.